SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017

Monday, November 7, 2016 Drug News J E 4

NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited ("Teva" or the "Company") (NYSE: TEVA) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Teva between February 10, 2015 and November 3, 2016, both dates inclusive (the "Class Period").

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").  

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Teva was involved in and/or had been involved in conduct that would result in an antitrust investigation by the U.S. Department of Justice and the State of Connecticut Office of the Attorney General; (2) the DOJ investigation and the misconduct may instigate U.S. prosecutors to file criminal charges against Teva for alleged price manipulation; (3) as a result, Teva lacked effective internal controls; and (4) consequently, Teva's public statements were materially false and misleading at all relevant times.

No Class has yet been certified in the above action. To discuss this action, or for any questions, please visit the firm's site: or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email Those who inquire by e-mail are encouraged to include their mailing address and telephone number.  If you suffered a loss in Teva, you have until January 5, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz 212-697-6484 |


To view the original version on PR Newswire, visit:

SOURCE Bronstein, Gewirtz & Grossman, LLC



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, ...
Lane Bryant's This Body Stands Strong Campaign Suc...